Implantation or Injectable Dosage Form New Animal Drugs; Hyaluronate Sodium Injection
other · Food and Drug Administration · Rule · Published 2006-07-12 · Effective 2006-07-12 · 71 FR 39204
Document
Document number
E6-10879
Federal Register citation
71 FR 39204
CFR reference
21 CFR 522
Type
Rule
Action
Final rule.
Category
other
Sub-agency
Food and Drug Administration
Publication date
2006-07-12
Effective date
2006-07-12
Abstract
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Pharmacia & Upjohn Co., a Division of Pfizer, Inc. The supplemental NADA provides for a revised food safety warning on labeling for hyaluronate sodium injectable solution.